PNEUMOCOCCAL IMMUNIZATION
Clinical trials for PNEUMOCOCCAL IMMUNIZATION explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL IMMUNIZATION trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL IMMUNIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Korean study to monitor prevenar 20 vaccine safety
⭐️ VACCINE ⭐️ Recruiting nowThis study checks the safety of the Prevenar 20 vaccine after it is already available in Korea. About 660 people aged 6 weeks and older who are prescribed the vaccine will take part. Researchers will track any side effects for 28 days after vaccination.
Matched conditions: PNEUMOCOCCAL IMMUNIZATION
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:40 UTC
-
New vaccine for infants aims to shield against 21 types of pneumococcal bacteria
Prevention Recruiting nowThis study tests a new vaccine (PCV21) in healthy infants to see if it safely helps their bodies build defenses against 21 types of pneumococcal bacteria, which can cause serious infections like pneumonia and meningitis. About 2,195 babies will receive four doses of either the ne…
Matched conditions: PNEUMOCOCCAL IMMUNIZATION
Phase: PHASE3 • Sponsor: Sanofi • Aim: Prevention
Last updated May 17, 2026 06:50 UTC